Insider Transactions in Q4 2025 at Neurocrine Biosciences Inc (NBIX)
Insider Transaction List (Q4 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 05
2025
|
William H Rastetter Director |
SELL
Open market or private sale
|
Direct |
18,000
-30.84%
|
$2,718,000
$151.82 P/Share
|
|
Nov 05
2025
|
William H Rastetter Director |
BUY
Exercise of conversion of derivative security
|
Direct |
18,000
+23.57%
|
$846,000
$47.89 P/Share
|
|
Nov 04
2025
|
Kyle Gano Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
300
-0.21%
|
$42,300
$141.97 P/Share
|
|
Nov 01
2025
|
Kyle Gano Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
613
+0.43%
|
-
|